1. Home
  2. LARK vs MCRB Comparison

LARK vs MCRB Comparison

Compare LARK & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • MCRB
  • Stock Information
  • Founded
  • LARK 1885
  • MCRB 2010
  • Country
  • LARK United States
  • MCRB United States
  • Employees
  • LARK N/A
  • MCRB N/A
  • Industry
  • LARK Major Banks
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LARK Finance
  • MCRB Health Care
  • Exchange
  • LARK Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • LARK 150.1M
  • MCRB 144.8M
  • IPO Year
  • LARK N/A
  • MCRB 2015
  • Fundamental
  • Price
  • LARK $26.50
  • MCRB $16.87
  • Analyst Decision
  • LARK
  • MCRB Hold
  • Analyst Count
  • LARK 0
  • MCRB 3
  • Target Price
  • LARK N/A
  • MCRB $14.33
  • AVG Volume (30 Days)
  • LARK 6.8K
  • MCRB 88.5K
  • Earning Date
  • LARK 10-29-2025
  • MCRB 11-05-2025
  • Dividend Yield
  • LARK 3.09%
  • MCRB N/A
  • EPS Growth
  • LARK 38.73
  • MCRB N/A
  • EPS
  • LARK 2.98
  • MCRB 0.62
  • Revenue
  • LARK $64,367,999.00
  • MCRB $351,000.00
  • Revenue This Year
  • LARK N/A
  • MCRB N/A
  • Revenue Next Year
  • LARK N/A
  • MCRB N/A
  • P/E Ratio
  • LARK $9.06
  • MCRB $26.91
  • Revenue Growth
  • LARK 12.95
  • MCRB N/A
  • 52 Week Low
  • LARK $20.75
  • MCRB $6.53
  • 52 Week High
  • LARK $31.04
  • MCRB $24.67
  • Technical
  • Relative Strength Index (RSI)
  • LARK 68.78
  • MCRB 51.80
  • Support Level
  • LARK $25.43
  • MCRB $12.48
  • Resistance Level
  • LARK $26.15
  • MCRB $14.35
  • Average True Range (ATR)
  • LARK 0.47
  • MCRB 1.18
  • MACD
  • LARK 0.18
  • MCRB 0.22
  • Stochastic Oscillator
  • LARK 99.48
  • MCRB 80.50

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: